1. The Analysis of PTPN6 for Bladder Cancer: An Exploratory Study Based on TCGA
   Chengquan Shen et al, 2020, Disease Markers CrossRef
2. A Transcriptional Signature of IL-2 Expanded Natural Killer Cells Predicts More Favorable Prognosis in Bladder Cancer
   Yuhan Sun et al, 2021, Frontiers in Immunology CrossRef
3. Herpesvirus entry mediator as a potential biomarker in breast cancer compared with conventional cytotoxic T‑lymphocyte‑associated antigen 4
   Alia Aldahlawi et al, 2023, Biomedical Reports CrossRef
4. Cuproptosis correlates with immunosuppressive tumor microenvironment based on pan-cancer multiomics and single-cell sequencing analysis
   Yan Qin et al, 2023, Molecular Cancer CrossRef
5. Follicular lymphoma of the lower female genital tract: an indolent and localized extranodal follicular lymphoma with mutation of TNFRSF14
   Luana Santos Louro et al, 2024, Leukemia & Lymphoma CrossRef
6. The role of costimulatory molecules in glioma biology and immune microenvironment
   Ji Wang et al, 2022, Frontiers in Genetics CrossRef
7. Identification of a Prognosis-Related Risk Signature for Bladder Cancer to Predict Survival and Immune Landscapes
   Linhui Wang et al, 2021, Journal of Immunology Research CrossRef
8. Single-Cell Sequencing Unveils the Heterogeneity of Nonimmune Cells in Chronic Apical Periodontitis
   Xinwei Lin et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
9. Identification of Immune-Related Genes Associated With Bladder Cancer Based on Immunological Characteristics and Their Correlation With the Prognosis
   Zhen Kang et al, 2021, Frontiers in Genetics CrossRef
10. The Pyroptosis-Related Risk Genes APOBEC3D, TNFRSF14, and RAC2 Were Used to Evaluate Prognosis and as Tumor Suppressor Genes in Breast Cancer
    Qian Chen et al, 2022, Journal of Oncology CrossRef